MyAverix Finance
US · Healthcare
Greater Cannabis Company Inc (GCAN)
Drug Manufacturers - Specialty & Generic
Greater Cannabis Company Inc (GCAN) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GCAN
Greater Cannabis Company Inc (GCAN) — FAQ
What is GCAN's P/E ratio?
The price-to-earnings (P/E) ratio for Greater Cannabis Company Inc (GCAN) is 18.00 (data as of 2026-05-23).
Does Greater Cannabis Company Inc pay a dividend?
Dividend yield is not available in the current snapshot for Greater Cannabis Company Inc (GCAN). Check the MyAverix Finance app for the latest dividend data.
What sector is Greater Cannabis Company Inc in?
Greater Cannabis Company Inc (GCAN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is GCAN listed on?
GCAN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.